Plain-English translation of NCT07642882 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS)—a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain—to see if it can help reduce chronic pain in people with fibromyalgia. Some participants will receive active treatment, while others will receive a sham (fake) treatment that looks the same but doesn't deliver real stimulation. The trial wants to understand whether the treatment works, and which patients respond best to it.
Fibromyalgia causes widespread chronic pain that can be difficult to treat with current medications alone. This trial exists to see whether brain stimulation could offer a new way to relieve pain and whether it works differently in people who also have depression.
You likely qualify if…
You likely don't qualify if…
You will first have a brain MRI scan to map where the stimulation should be targeted. Then you'll receive 10 sessions of brain stimulation over about 2 months—5 daily sessions in the first week, followed by one session per week for 3 weeks, then one session every 15 days. Each session lasts 30–40 minutes. You'll complete questionnaires and have brain tests (including EEG) at the start, after the intensive phase, and 2 weeks after treatment ends to measure changes in your pain and brain activity.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France